abstract |
The present invention relates to methods of modulating the immune response in the field of autoimmune diseases via targeting of the aryl hydrocarbon receptor (AhR) with inhibitors such as flavones antisense or interfering RNA molecules or 2-methyl-2H-pyrazole-3-carboxylic acid- (2-methyl-4-o-tolylazophenyl) -amide. |